<DOC>
	<DOCNO>NCT00836602</DOCNO>
	<brief_summary>The primary purpose study evaluate safety tolerability multiple oral dos BMS-779788 healthy subject</brief_summary>
	<brief_title>Multiple-Dose Study Evaluate Safety , Pharmacokinetics Pharmacodynamics BMS-779788 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Men woman ( child bear potential ) age 18 45 Healthy subject determine clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination Women child bear potential Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG clinical laboratory determination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>